Tranexamic Acid Can Be Safely Given to Patients with G6PD Deficiency
Tranexamic acid is safe to administer to patients with G6PD deficiency and does not cause hemolysis in this population. Unlike certain oxidant drugs that are contraindicated in G6PD deficiency, tranexamic acid is an antifibrinolytic agent that works through a completely different mechanism and has no oxidative properties that would trigger hemolytic anemia.
Why Tranexamic Acid is Safe in G6PD Deficiency
The confusion around this question likely stems from the fact that G6PD deficiency requires avoidance of specific oxidant medications. However, tranexamic acid is mechanistically distinct:
- Tranexamic acid is NOT an oxidant drug - It works by inhibiting fibrinolysis through reversible binding to plasminogen, preventing the dissolution of fibrin clots 1
- No hemolytic mechanism - The drug does not generate oxidative stress that would deplete glutathione or cause red blood cell membrane damage in G6PD-deficient patients
- Not listed in G6PD contraindications - Comprehensive reviews of medications to avoid in G6PD deficiency consistently exclude tranexamic acid from their lists 2, 3
Drugs That ARE Contraindicated in G6PD Deficiency
For context, the medications with solid evidence requiring avoidance in G6PD-deficient patients include 3:
- Dapsone
- Methylthioninium chloride (methylene blue) 4
- Nitrofurantoin
- Phenazopyridine
- Primaquine (particularly >5 days in severe deficiency) 5, 6
- Rasburicase 7, 8
- Tolonium chloride (toluidine blue)
These drugs cause hemolysis through oxidative stress mechanisms that overwhelm the reduced antioxidant capacity in G6PD-deficient red blood cells.
Clinical Application
Administer tranexamic acid using standard dosing without modification:
- For trauma/bleeding: 1 g IV over 10 minutes, followed by 1 g infusion over 8 hours 9
- For surgery: Standard prophylactic or therapeutic doses as indicated 10
- No special monitoring required beyond standard clinical assessment for the underlying bleeding condition
The only dose adjustments needed for tranexamic acid relate to renal impairment, not G6PD status 1.
Important Caveat
While tranexamic acid itself is safe, be vigilant about other medications the patient may receive concurrently. For example, if treating methemoglobinemia in a G6PD-deficient patient, methylene blue should be avoided and ascorbic acid used instead 4. Similarly, ensure prophylactic antibiotics or antimalarials don't include contraindicated agents like primaquine or dapsone 11, 6.